Concepedia

Publication | Open Access

Glimepiride Versus Metformin as Monotherapy in Pediatric Patients With Type 2 Diabetes

141

Citations

8

References

2007

Year

Abstract

Glimepiride reduced A1C similarly to metformin with greater weight gain, and there was comparable safety over 24 weeks in the treatment of pediatric subjects with type 2 diabetes.

References

YearCitations

Page 1